This report provides a comprehensive analysis of the global Hydrotalcite API market, an essential inorganic antacid used for gastric acid neutralization and mucosal protection. The market is projected to experience steady growth through 2032, driven by demand across various pharmaceutical formulations such as chewable tablets and suspensions. Covering key segments including BP and CP grades, the study evaluates regional dynamics, competitive landscapes, and major industry players. It further examines cost structures, supply chain dependencies, and emerging opportunities for both originator and generic pharmaceutical companies.

Market Overview

Global Market Size and Forecast

The global Hydrotalcite API market size is predicted to grow from US$ 17.54 million in 2025 to US$ 26.90 million in 2032, representing a compound annual growth rate (CAGR) of 6.1% from 2026 to 2032.

Product Definition and Functionality

Hydrotalcite API (magnesium aluminum carbonate) is an inorganic pharmaceutical active ingredient belonging to layered double hydroxides. It is composed mainly of magnesium, aluminum, hydroxide layers, and interlayer carbonate ions.

Functions:

• Antacid Activity: It neutralizes gastric acid and forms a protective barrier over the gastric mucosa, thereby reducing irritation.
• Adsorption: It can adsorb bile acids and pepsin, contributing to mucosal protection.

2025 Market Statistics

• Global Production: 3,283 tons
• Average Price: USD 5,462 per ton
• Total Production Capacity: Approximately 6,000 tons
• Industry Gross Margin: Around 25%–35%

Cost Structure

• Direct Materials: Approximately 72%
• Manufacturing Overhead: Approximately 24%
• Labor Costs: Approximately 4%

Industry Chain

• Upstream: Raw material suppliers providing aluminum salts, magnesium salts, and sodium carbonate.
• Downstream: Manufacturers of hydrotalcite formulations.

Regional Market Analysis

United States

The United States market for Hydrotalcite API is projected to experience growth from 2025 through 2032.

China

The China market for Hydrotalcite API is projected to experience growth from 2025 through 2032.

Europe

The Europe market for Hydrotalcite API is projected to experience growth from 2025 through 2032.

Market Segmentation

By Type

• BP Grade
• CP Grade
• Others

By Customer Base

• Originator Pharmaceutical Companies
• Generic Pharmaceutical Companies

By Applicable Formulation

• Chewable Tablet
• Suspension
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Industry Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolio, and market penetration:

• Kyowa Chemical
• IL-YANG Pharmaceutical
• Hunan Jiudian Hongyang Pharmaceutical
• Taishan Xinning Pharmaceutical
• Chongqing Pharscin Pharmaceutical
• Henan Jingkang Pharmaceutical
• Hubei Ouly Pharmaceutical

Market Concentration

In 2025, the global two largest companies held a significant portion of the total market revenue share.

About the Report

Research Scope

LP Information, Inc. (LPI)'s newest research report, the “Hydrotalcite API Industry Forecast,” reviews total world Hydrotalcite API sales in 2025. It provides a comprehensive analysis by region and market sector of projected Hydrotalcite API sales for 2026 through 2032. The report includes detailed analysis in US$ millions, with sales broken down by region, market sector, and sub-sector.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global Hydrotalcite API landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments and M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on:

• Hydrotalcite API portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Methodology

This study evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by Type, Applicable Formulation, geography, and market size to highlight emerging pockets of opportunity. The report utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the global Hydrotalcite API industry.

Key Questions Addressed

• What is the 10-year outlook for the global Hydrotalcite API market?
• What factors are driving Hydrotalcite API market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Hydrotalcite API market opportunities vary by end market size?
• How does Hydrotalcite API break out by Type and by Applicable Formulation?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Hydrotalcite API Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Hydrotalcite API by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Hydrotalcite API by Country/Region, 2021, 2025 & 2032

  • 2.2 Hydrotalcite API Segment by Type

    • 2.2.1 BP Grade

    • 2.2.2 CP Grade

    • 2.2.3 Others

    • 2.2.4 Hydrotalcite API Sales by Type

      • 2.2.4.1 Global Hydrotalcite API Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Hydrotalcite API Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Hydrotalcite API Sale Price by Type (2021-2026)

  • 2.3 Hydrotalcite API Segment by Customer Base

    • 2.3.1 Originator Pharmaceutical Companies

    • 2.3.2 Generic Pharmaceutical Companies

    • 2.3.3 Hydrotalcite API Sales by Customer Base

      • 2.3.3.1 Global Hydrotalcite API Sales Market Share by Customer Base (2021-2026)
      • 2.3.3.2 Global Hydrotalcite API Revenue and Market Share by Customer Base (2021-2026)
      • 2.3.3.3 Global Hydrotalcite API Sale Price by Customer Base (2021-2026)

  • 2.4 Hydrotalcite API Segment by Applicable Formulation

    • 2.4.1 Chewable Tablet

    • 2.4.2 Suspension

    • 2.4.3 Others

    • 2.4.4 Hydrotalcite API Sales by Applicable Formulation

      • 2.4.4.1 Global Hydrotalcite API Sale Market Share by Applicable Formulation (2021-2026)
      • 2.4.4.2 Global Hydrotalcite API Revenue and Market Share by Applicable Formulation (2021-2026)
      • 2.4.4.3 Global Hydrotalcite API Sale Price by Applicable Formulation (2021-2026)

• 3 Global by Company

  • 3.1 Global Hydrotalcite API Breakdown Data by Company

    • 3.1.1 Global Hydrotalcite API Annual Sales by Company (2021-2026)

    • 3.1.2 Global Hydrotalcite API Sales Market Share by Company (2021-2026)

  • 3.2 Global Hydrotalcite API Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Hydrotalcite API Revenue by Company (2021-2026)

    • 3.2.2 Global Hydrotalcite API Revenue Market Share by Company (2021-2026)

  • 3.3 Global Hydrotalcite API Sale Price by Company

  • 3.4 Key Manufacturers Hydrotalcite API Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Hydrotalcite API Product Location Distribution

    • 3.4.2 Players Hydrotalcite API Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Hydrotalcite API by Geographic Region

  • 4.1 World Historic Hydrotalcite API Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Hydrotalcite API Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Hydrotalcite API Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Hydrotalcite API Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Hydrotalcite API Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Hydrotalcite API Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Hydrotalcite API Sales Growth

  • 4.4 APAC Hydrotalcite API Sales Growth

  • 4.5 Europe Hydrotalcite API Sales Growth

  • 4.6 Middle East & Africa Hydrotalcite API Sales Growth

• 5 Americas

  • 5.1 Americas Hydrotalcite API Sales by Country

    • 5.1.1 Americas Hydrotalcite API Sales by Country (2021-2026)

    • 5.1.2 Americas Hydrotalcite API Revenue by Country (2021-2026)

  • 5.2 Americas Hydrotalcite API Sales by Type (2021-2026)

  • 5.3 Americas Hydrotalcite API Sales by Applicable Formulation (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Hydrotalcite API Sales by Region

    • 6.1.1 APAC Hydrotalcite API Sales by Region (2021-2026)

    • 6.1.2 APAC Hydrotalcite API Revenue by Region (2021-2026)

  • 6.2 APAC Hydrotalcite API Sales by Type (2021-2026)

  • 6.3 APAC Hydrotalcite API Sales by Applicable Formulation (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Hydrotalcite API by Country

    • 7.1.1 Europe Hydrotalcite API Sales by Country (2021-2026)

    • 7.1.2 Europe Hydrotalcite API Revenue by Country (2021-2026)

  • 7.2 Europe Hydrotalcite API Sales by Type (2021-2026)

  • 7.3 Europe Hydrotalcite API Sales by Applicable Formulation (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Hydrotalcite API by Country

    • 8.1.1 Middle East & Africa Hydrotalcite API Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Hydrotalcite API Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Hydrotalcite API Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Hydrotalcite API Sales by Applicable Formulation (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Hydrotalcite API

  • 10.3 Manufacturing Process Analysis of Hydrotalcite API

  • 10.4 Industry Chain Structure of Hydrotalcite API

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Hydrotalcite API Distributors

  • 11.3 Hydrotalcite API Customer

• 12 World Forecast Review for Hydrotalcite API by Geographic Region

  • 12.1 Global Hydrotalcite API Market Size Forecast by Region

    • 12.1.1 Global Hydrotalcite API Forecast by Region (2027-2032)

    • 12.1.2 Global Hydrotalcite API Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Hydrotalcite API Forecast by Type (2027-2032)

  • 12.7 Global Hydrotalcite API Forecast by Applicable Formulation (2027-2032)

• 13 Key Players Analysis

  • 13.1 Kyowa Chemical

    • 13.1.1 Kyowa Chemical Company Information

    • 13.1.2 Kyowa Chemical Hydrotalcite API Product Portfolios and Specifications

    • 13.1.3 Kyowa Chemical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Kyowa Chemical Main Business Overview

    • 13.1.5 Kyowa Chemical Latest Developments

  • 13.2 IL-YANG Pharmaceutical

    • 13.2.1 IL-YANG Pharmaceutical Company Information

    • 13.2.2 IL-YANG Pharmaceutical Hydrotalcite API Product Portfolios and Specifications

    • 13.2.3 IL-YANG Pharmaceutical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 IL-YANG Pharmaceutical Main Business Overview

    • 13.2.5 IL-YANG Pharmaceutical Latest Developments

  • 13.3 Hunan Jiudian Hongyang Pharmaceutical

    • 13.3.1 Hunan Jiudian Hongyang Pharmaceutical Company Information

    • 13.3.2 Hunan Jiudian Hongyang Pharmaceutical Hydrotalcite API Product Portfolios and Specifications

    • 13.3.3 Hunan Jiudian Hongyang Pharmaceutical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Hunan Jiudian Hongyang Pharmaceutical Main Business Overview

    • 13.3.5 Hunan Jiudian Hongyang Pharmaceutical Latest Developments

  • 13.4 Taishan Xinning Pharmaceutical

    • 13.4.1 Taishan Xinning Pharmaceutical Company Information

    • 13.4.2 Taishan Xinning Pharmaceutical Hydrotalcite API Product Portfolios and Specifications

    • 13.4.3 Taishan Xinning Pharmaceutical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Taishan Xinning Pharmaceutical Main Business Overview

    • 13.4.5 Taishan Xinning Pharmaceutical Latest Developments

  • 13.5 Chongqing Pharscin Pharmaceutical

    • 13.5.1 Chongqing Pharscin Pharmaceutical Company Information

    • 13.5.2 Chongqing Pharscin Pharmaceutical Hydrotalcite API Product Portfolios and Specifications

    • 13.5.3 Chongqing Pharscin Pharmaceutical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Chongqing Pharscin Pharmaceutical Main Business Overview

    • 13.5.5 Chongqing Pharscin Pharmaceutical Latest Developments

  • 13.6 Henan Jingkang Pharmaceutical

    • 13.6.1 Henan Jingkang Pharmaceutical Company Information

    • 13.6.2 Henan Jingkang Pharmaceutical Hydrotalcite API Product Portfolios and Specifications

    • 13.6.3 Henan Jingkang Pharmaceutical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Henan Jingkang Pharmaceutical Main Business Overview

    • 13.6.5 Henan Jingkang Pharmaceutical Latest Developments

  • 13.7 Hubei Ouly Pharmaceutical

    • 13.7.1 Hubei Ouly Pharmaceutical Company Information

    • 13.7.2 Hubei Ouly Pharmaceutical Hydrotalcite API Product Portfolios and Specifications

    • 13.7.3 Hubei Ouly Pharmaceutical Hydrotalcite API Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Hubei Ouly Pharmaceutical Main Business Overview

    • 13.7.5 Hubei Ouly Pharmaceutical Latest Developments

• 14 Research Findings and Conclusion